YAMAMOTO NUTRITION - KAMIKAZE*
Food supplement declared in France, declaration No 2023-5-1097, decision dated 24 May 2023
YAMAMOTO NUTRITION - KAMIKAZE* (YAMAMOTO) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition.
- Brand
- YAMAMOTO
- Food business operator placing the product on the market
- YAMAMOTO S.P.A.
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Poudre
- Daily dose
- 1 mesure (17,5 g) par jour
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Prise concomittante d'alcool
- Objectives stated by the manufacturer (these are not authorised claims)
- Sport
- Flavourings
- ORANGE
Declaration 243752, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Citrulline | not declared |
| Monohydrate de créatine | not declared |
| L-leucine | not declared |
| Bêta-alanine | not declared |
| L-isoleucine | not declared |
| L-valine | not declared |
| Taurine | not declared |
| Tyrosine | not declared |
| Glutathion | not declared |
| Caféine | not declared |
Additives
E322, E330, E551, E955, E950, E160a
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Ne pas dépasser la dose journalière recommandée. Les compléments alimentaires ne doivent pas être utilisés comme substituts d'un régime alimentaire varié. Une alimentation variée et équilibrée et un mode de vie sain sont importants. Tenir hors de la portée des jeunes enfants. En raison de la présence de créatine, le produit est destiné aux adultes uniquement. Ne convient pas aux femmes enceintes et aux enfants ou pendant des périodes prolongées sans consulter un médecin. Ne pas dépasser la dose journalière totale de 400 mg de caféine, toutes sources confondues. Ne prenez pas le produit avant le coucher, en liaison avec la consommation d'alcool ou dans les heures qui précèdent le sommeil. Conserver dans un endroit frais et sec, loin des sources de chaleur et de la lumière du soleil.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Monohydrate de créatine
Read the warning, when it applies and the studies cited
Creatine Monohydrate
Route of administration: Oral
Cautions and warnings
When using this product you may gain weight (Volek and Rawson 2004; Bemben et al. 2001; Mihic et al. 2000).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (Pline and Smith 2005; Pritchard and Kalra 1998).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Taurine
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Tyrosine
Read the warning, when it applies and the studies cited
L-TYROSINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- Caféine
Read the warning, when it applies and the studies cited
CAFFEINE
Route of administration: Oral (Higdon and Frei 2006)
Cautions and warnings
Applies to products providing 100 mg to 400 mg caffeine, per day1.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have high blood pressure or glaucoma (Cornelis and El-Sohemy 2007, Chandrasekaran et al. 2005, Noordzij et al. 2005, Avisar et al. 2002, Arya et al. 2000, Jee et al. 1999, Creighton and Stanton 1990).
7 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
1Note: This statement is also required at subtherapeutic quantities for products providing 40 mg or more caffeine per day from all sources for Class II and III applications.
Applies to products providing more than 300 mg caffeine, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant, breastfeeding, or attempting to conceive (Nawrot et al. 2003).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 400 mg or more caffeine, per day.
When using this product avoid taking other health products, foods or beverages that contain caffeine and/or increase blood pressure (FDA 2023; Bui et al. 2006; Bouchard et al. 2005; Haller et al. 2005; NIH 2004; Berardi et al. 2002; Vahedi et al. 2000; Zimmerman 1992).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing more than 400 mg caffeine per day.
Do not use if you have high blood pressure or glaucoma (Cornelis and El-Sohemy 2007, Chandrasekaran et al. 2005, Noordzij et al. 2005, Avisar et al. 2002, Arya et al. 2000, Jee et al. 1999, Creighton and Stanton 1990).
7 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if hypersensitivity/allergy occurs (Infante et al. 2003; Hinrichs et al. 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 200 mg or more caffeine, per day.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms such as chest pain and irregular heartbeat occur (Higgins and Babu 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 400 mg caffeine, per day.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if nervousness, anxiety, insomnia, tremor and/or headache occur (IOM 2001, Zhang 2001, Sawynok 1995).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except those making a diuretic claim1.
When using this product diuretic effect may occur.
1Note: This statement is also required at subtherapeutic quantities for products providing 40 mg or more caffeine per day from all sources for Class II and III applications.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- YAMAMOTO NUTRITION - KAMIKAZE YAMAMOTO S.P.A., declared in 2022 : different composition: 2 ingredient(s) added, 1 missing
- YAMAMOTO NUTRITION - KAMIKAZE YAMAMOTO S.P.A., declared in 2022 : different composition: 0 ingredient(s) added, 1 missing
- YAMAMOTO NUTRITION - KAMIKAZE YAMAMOTO S.P.A., declared in 2019, earlier declaration, replaced by the 2023 declaration : different composition: 2 ingredient(s) added, 1 missing
Brand : YAMAMOTO
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.